A detailed history of Morgan Stanley transactions in Biomerica Inc stock. As of the latest transaction made, Morgan Stanley holds 315 shares of BMRA stock, worth $88. This represents 0.0% of its overall portfolio holdings.

Number of Shares
315
Previous 565 44.25%
Holding current value
$88
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.28 - $0.49 $70 - $122
-250 Reduced 44.25%
315 $0
Q2 2024

Oct 17, 2024

SELL
$0.42 - $0.86 $6 - $12
-15 Reduced 2.59%
565 $0
Q2 2024

Aug 14, 2024

SELL
$0.42 - $0.86 $6 - $12
-15 Reduced 2.59%
565 $0
Q1 2024

Oct 17, 2024

BUY
$0.82 - $1.29 $12 - $19
15 Added 2.65%
580 $0
Q1 2024

Aug 16, 2024

SELL
$0.82 - $1.29 $258 - $406
-315 Reduced 35.2%
580 $0
Q1 2024

May 15, 2024

SELL
$0.82 - $1.29 $258 - $406
-315 Reduced 35.2%
580 $0
Q4 2023

Aug 16, 2024

BUY
$0.71 - $1.65 $234 - $544
330 Added 58.41%
895 $1,000
Q2 2023

Aug 14, 2023

BUY
$1.12 - $1.87 $16 - $28
15 Added 1.7%
895 $1,000
Q1 2023

May 15, 2023

SELL
$1.86 - $3.56 $5 - $10
-3 Reduced 0.34%
880 $1,000
Q4 2022

Feb 14, 2023

BUY
$2.98 - $4.17 $5 - $8
2 Added 0.23%
883 $2,000
Q3 2022

Nov 14, 2022

SELL
$2.61 - $3.98 $1,954 - $2,981
-749 Reduced 45.95%
881 $3,000
Q2 2022

Oct 27, 2022

SELL
$2.7 - $4.69 $2,394 - $4,160
-887 Reduced 35.24%
1,630 $5,000
Q2 2022

Aug 15, 2022

SELL
$2.7 - $4.69 $2,394 - $4,160
-887 Reduced 35.24%
1,630 $5,000
Q1 2022

Oct 27, 2022

BUY
$3.59 - $4.64 $3,184 - $4,115
887 Added 54.42%
2,517 $12,000
Q1 2022

May 13, 2022

BUY
$3.59 - $4.64 $1,389 - $1,795
387 Added 18.17%
2,517 $12,000
Q4 2021

Feb 14, 2022

BUY
$3.89 - $6.71 $1,886 - $3,254
485 Added 29.48%
2,130 $8,000
Q3 2021

Nov 15, 2021

BUY
$3.54 - $5.13 $5,823 - $8,438
1,645 New
1,645 $7,000

Others Institutions Holding BMRA

About BIOMERICA INC


  • Ticker BMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,427,700
  • Market Cap $3.76M
  • Description
  • Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...
More about BMRA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.